Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yu Ru Kou PhD"'
Autor:
Kun-Ming Wu MD, Chih-Wen Chi PhD, Jerry Cheng-Yen Lai PhD, Yu-Jen Chen MD, PhD, Yu Ru Kou PhD
Publikováno v:
Cancer Control, Vol 27 (2020)
TLC388, a camptothecin-derivative targeting topoisomerase I, is a potential anticancer drug. In this study, its effect on A549 and H838 human non-small cell lung cancer (NSCLC) cells was investigated. Cell viability and proliferation were determined
Externí odkaz:
https://doaj.org/article/c99f74ce3f0e49a48c17888e7e907ac7
